Fig. 3
From: CD133 significance in glioblastoma development: in silico and in vitro study
The half-maximal inhibitory concentration (IC50) of temozolomide and the effect of CD133 silencing on the cell viability of U87MG cells. A The IC50 of temozolomide on U87MG cells is 693.0 µg/ml. B The effect of shock and scramble transfection on the viability of U87MG cells. The shock of transfection and transfecting scramble is not associated with significant cell viability change. C The effect of CD133 suppression on the cell viability of U87MG cells. CD133 silencing does not significantly alter the cell viability of U87MG cells. The MTT results are displayed as displayed as mean ± standard deviation (SD). ns: non-significant, ***P-value ≤ 0.001, and ****P-value ≤ 0.0001